Salivary Biomarkers and Oral Health in Liver Transplant Recipients, with an Emphasis on Diabetes

• Main Authors: Annika Emilia Norrman, Taina Tervahartiala, Ella Sahlberg, Timo Sorsa, Hellevi Ruokonen, Lisa Grönroos, Jukka H. Meurman, Helena Isoniemi, Arno Nordin, Fredrik Åberg, Jaana Helenius-Hietala
• Format: Article
• Language: English
• Published: MDPI AG 2021-04-01
• Series: Diagnostics
• Subjects: periodontitis; teeth; liver disease; oral infections; saliva; salivary biomarkers
• Online Access: https://www.mdpi.com/2075-4418/11/4/662

Salivary biomarkers have been linked to various systemic diseases. We examined the association between salivary biomarkers, periodontal health, and microbial burden in liver transplant (LT) recipients with and without diabetes, after transplantation. We hypothesized that diabetic recipients would exhibit impaired parameters. This study included 84 adults who received an LT between 2000 and 2006 in Finland. Dental treatment preceded transplantation. The recipients were re-examined, on average, six years later. We evaluated a battery of salivary biomarkers, microbiota, and subjective oral symptoms. Periodontal health was assessed, and immunosuppressive treatments were recorded. Recipients with impaired periodontal health showed higher matrix metalloproteinase-8 (MMP-8) levels (<i>p</i> < 0.05) and MMP-8/tissue inhibitor of matrix metalloproteinase 1 (TIMP1) ratios (<i>p</i> < 0.001) than recipients with good periodontal health. Diabetes post-LT was associated with impaired periodontal health (<i>p</i> < 0.05). No difference between groups was found in the microbial counts. Salivary biomarker levels did not seem to be affected by diabetes. However, the advanced pro-inflammatory state induced by and associated with periodontal inflammation was reflected in the salivary biomarker levels, especially MMP-8 and the MMP-8/TIMP-1 molar ratio. Thus, these salivary biomarkers may be useful for monitoring the oral inflammatory state and the course of LT recipients.